—

Dr. Reddy’s Laboratories Ltd ADR(RDY)— 同类公司组

数据截至2026-09-25 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

Dr. Reddy’s Laboratories Ltd ADR的Closelook综合评分为45/100,在同类公司组内排名第11位(共11家)——组内评分最高的是Halozyme Therapeutics Inc(74/100)。

名称综合动量质量估值信号距52周高点
RDY Dr. Reddy’s Laboratories Ltd ADR45204163info21%
LNTH Lantheus Holdings Inc60647460info10.8%
KNSA Kiniksa Pharmaceuticals Ltd56895721info9.5%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock54895642ok6.6%
BHC.TO Bausch Health Companies Inc54497084info27.3%
GALDY GALDERMA GROUP AG53385727info14.8%
ALM.MC Almirall S.A.52224467warn24.2%
HALO Halozyme Therapeutics Inc74959446ok2.5%
DXCM DexCom Inc66838037neutral5.5%
ARGX argenx NV ADR64747329ok10.6%
ONC BeiGene, Ltd.64796232ok6.3%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-09-25

Quick answers

Dr. Reddy’s Laboratories Ltd ADR在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:Lantheus Holdings Inc (LNTH)、Kiniksa Pharmaceuticals Ltd (KNSA)、Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)、Bausch Health Companies Inc (BHC.TO)、GALDERMA GROUP AG (GALDY)、Almirall S.A. (ALM.MC)、Halozyme Therapeutics Inc (HALO)、DexCom Inc (DXCM)等。

RDY相对同类公司的评分如何?

Dr. Reddy’s Laboratories Ltd ADR的综合评分为45/100,组内排名第11位(共11家),截至2026-09-25;组内最高综合评分为Halozyme Therapeutics Inc(74/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.